Американское общество гирудотерапии

Coexpression of BiP increased antithrombotic hirudin production in recombinant Saccharomyces cerevisiae

Comparative study published in J Biotechnol (2003)

Последнее обновление: June 18, 2026Рецензент: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Observational studyФармакология секрета слюнных желёзРазработка лекарственных препаратовKim MD et al. · J Biotechnol, 2003

Abstract

In order to increase a production level of antithrombotic hirudin, BiP was simultaneously expressed in recombinant Saccharomyces cerevisiae strains carrying ten and 15 copies of the hirudin expression cassette integrated in the chromosome. Coexpression of BiP greatly enhanced both cell growth and hirudin production in recombinant S. cerevisiae. Maximum hirudin concentration of 36 mg l(-1) was obtained from batch culture of the ten copy-number transformant concomitantly harboring an episomal copy of the BiP gene under the control of the GAL1 promoter, which is corresponding to a 2.5-fold increase compared with the control strain carrying the genomic BiP gene only. The mean size of the recombinant yeast cells expressing the BiP gene remained at a relatively constant level compared with the control strains of which size increased after the onset of hirudin expression by the GAL10 promoter.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeComparative StudyJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsCell DivisionCells, CulturedEscherichia coliFibrinolytic AgentsFungal ProteinsGalactoseGene Expression Regulation, FungalGlucoseHSP70 Heat-Shock ProteinsHirudinsMutagenesis, InsertionalRecombinant Proteins

Резюме

Coexpression of BiP chaperone with hirudin expression cassette in S. cerevisiae enhanced cell growth and hirudin production 2.5-fold; maximum 36 mg/L from batch culture.

Почему это важно для гирудотерапии

This study coexpressed BiP in recombinant Saccharomyces cerevisiae carrying ten and fifteen chromosomally integrated copies of a hirudin expression cassette to boost antithrombotic hirudin production. Maximum hirudin concentration reached 36 mg/L from batch culture of the ten-copy strain with episomal BiP under the GAL1 promoter, a 2.5-fold increase over control, while maintaining cell size stability. The abstract describes hirudin only as an antithrombotic agent and makes no mention of leeches, the leech secretome, or hirudotherapy. There is no defensible connection to ASH's domain based on this abstract. This is a yeast bioproduction study with no clinical or in-vivo data.

Цитирование

Coexpression of BiP increased antithrombotic hirudin production in recombinant Saccharomyces cerevisiae.

Kim MD et al. · J Biotechnol, 2003

DOI

Связанный клинический контекст

Узнайте, как это исследование связано с клинической практикой

Salivary Gland SecretionAnti-Inflammatory MechanismsSalivary ComplexDrug PipelineDrug DevelopmentDirect Thrombin InhibitorsHirudinAnticoagulation CompoundsOtolaryngologyPost-Thrombotic SyndromeHemostasis

Добавлено в библиотеку ASH: May 27, 2026 · Последнее обновление сайта: June 18, 2026

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.